Newsletter FIT
Dashboard Search Watchlist Alerts Billing
SEARCH // ⌘K
Sign in Get started

Billing Watchlist

Product // Entity

NVG-291

Product mentions across the corpus

Search corpus

Overview

Publications

1

Articles

3

Mentions

3

First seen

Jun 15, 2026

Most recent

Jul 13, 2026

Recent articles

NervGen's Future.

Investment Ideas by Antonio · Jul 13, 2026 · mentions

They Were Paralyzed. Then They Joined a Peptide Trial.

Investment Ideas by Antonio · Jul 10, 2026 · mentions

NervGen: Chasing Ozempic for the Nervous System.

Investment Ideas by Antonio · Jun 15, 2026 · mentions

Publications discussing this product

Investment Ideas by Antonio

3 linked

Related entities

Topics

Spinal cord injury · 3 biotech investing · 2 Peptide therapeutics · 2 clinical trials · 1 CSPG/PTPσ pathway · 1 Neuroscience · 1 NVG-291 · 1 Nervous system ontology · 1 axon regeneration · 1 Axonal regeneration · 1 Longevity · 1 First principles biology · 1 Patient outcomes · 1

People

GLP-1 · 1 Antonio Linares · 1

Companies

NervGen · 3 Immunity Bio · 1 Case Western · 1

Other

CSPG · 1 Epigenome · 1 Ozempic · 1 Nitric oxide synthase · 1 TAT peptide · 1 GLP-1 · 1
SEARCH // ESC

Type to search